Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Neuroface logo — EEG analysis tool for the observation of the futility-stoppi...

Neuroface

EEG analysis tool for the observation of the futility-stopping rule in clinical trials.

Founded 2020 Austria Austria 3 employees Health Care

General Information

Company Name Neuroface
Founded Year 2020
Location Austria Austria
Employees 3
Industries Health Care
Social

BounceWatch is an independent company data service, not affiliated with Neuroface. To contact Neuroface, visit neuroface.at.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Neuroface compare?

A PDF of Neuroface and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Neuroface soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Neuroface

Neuroface is a health care startup founded in 2020 and headquartered in Austria. The company's slogan, "EEG analysis tool for the observation of the futility-stopping rule in clinical trials," highlights its main focus. Neuroface specializes in data-driven mental health analysis software, offering the burnout detection web service El-index. This innovative tool leverages years of research and development in various mental disorders, including schizophrenia, depression, aggression, and post COVID-19 disorder. The company's web service provides quick, reliable, and cost-effective analysis of employees' mental states, enabling the prediction of burnout and the selection of the best human condition for reliable operation. Neuroface's scientific software is designed to detect mental disorders at an early stage, allowing for the tracking of medical treatment responses, even when clinical changes are imperceptible. Furthermore, the company tests the efficacy of treatments in daily clinical practice and detects the percentage of deviation from the normal subject. Despite not having disclosed any recent investment details, Neuroface's focus on leveraging technology for mental health analysis presents an intriguing prospect for potential investors seeking opportunities in the health care and tech sectors.

Business keywords: EEG analysis, mental health analysis, clinical trials, data-driven, pharmaceutical, biomarkers, Neurometer corp, psychiatry, Neuroface, burnout detection, HRM, workplace wellbeing, schizophrenia, depression

No funding data available for Neuroface yet.

Neuroface Alternatives & Competitors

View All Alternatives
Neuroface vs
Pharmaserve-Lilly S.A.C.I.
Pharmaserve-Lilly S.A.C.I. Greece

Καλώς ήλθατε στο επίσημο κανάλι επικοινωνίας της ΦΑΡΜΑΣΕΡΒ-ΛΙΛΛΥ στο LinkedIn.

160 employees
Health Care, Pharmaceutical
Neuroface vs
Altimate Healthcare: Psychiatry for All
Altimate Healthcare: Psychiatry for All United States

Digitally-enabled specialty care for serious mental illness

Series A
1 employees
Health Care, Information Technology
Neuroface vs
Cumulus Neuroscience
Cumulus Neuroscience United Kingdom

Accelerating CNS Clinical Trials

Equity
34 employees
Health Care
View all alternatives

FAQ About Neuroface

EEG analysis tool for the observation of the futility-stopping rule in clinical trials.
Neuroface was founded in 2020.
Neuroface is headquartered in Austria.
Neuroface operates in Health Care. Its work centres on EEG analysis, mental health analysis, clinical trials and data-driven.
Neuroface has approximately 3 employees.
Top alternatives and competitors to Neuroface include Pharmaserve-Lilly S.A.C.I., Altimate Healthcare: Psychiatry for All, Cumulus Neuroscience, Brainify.AI, Courage Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Neuroface and Pharmaserve-Lilly S.A.C.I. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Neuroface, https://bouncewatch.com/company/neuroface, updated 27 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes